Anti-Inflammatory, Antioxidant, and Anti-Atherosclerotic Effects of Natural Supplements on Patients with FMF-Related AA Amyloidosis: A Non-Randomized 24-Week Open-Label Interventional Study
dc.authorid | GARCIA-BOURNISSEN, FACUNDO/0000-0002-8732-247X | |
dc.authorid | Poddighe, Dimitri/0000-0001-6431-9334 | |
dc.authorid | Ucuncuoglu, Didar/0000-0002-2640-5976 | |
dc.authorid | Demirkaya, Erkan/0000-0003-4525-1789 | |
dc.authorid | sezer, siren/0000-0002-7326-8388 | |
dc.authorid | Stenvinkel, Peter/0000-0002-8785-4820 | |
dc.authorid | honca, tevfik/0000-0003-3723-1374 | |
dc.authorscopusid | 57190093613 | |
dc.authorscopusid | 13003928900 | |
dc.authorscopusid | 57217041113 | |
dc.authorscopusid | 6507293750 | |
dc.authorscopusid | 57762018200 | |
dc.authorscopusid | 6506823277 | |
dc.authorscopusid | 15758674100 | |
dc.authorwosid | GARCIA-BOURNISSEN, FACUNDO/E-8286-2015 | |
dc.authorwosid | Poddighe, Dimitri/AAI-5712-2020 | |
dc.authorwosid | Ucuncuoglu, Didar/B-1929-2016 | |
dc.authorwosid | Demirkaya, Erkan/F-5082-2019 | |
dc.authorwosid | sezer, siren/JYQ-2550-2024 | |
dc.contributor.author | Romano, Micol | |
dc.contributor.author | Garcia-Bournissen, Facundo | |
dc.contributor.author | Piskin, David | |
dc.contributor.author | Rodoplu, Ulkumen | |
dc.contributor.author | Piskin, Lizzy | |
dc.contributor.author | Elzagallaai, Abdelbaset A. | |
dc.contributor.author | Demirkaya, Erkan | |
dc.date.accessioned | 2024-07-05T15:17:42Z | |
dc.date.available | 2024-07-05T15:17:42Z | |
dc.date.issued | 2022 | |
dc.department | Atılım University | en_US |
dc.department-temp | [Romano, Micol; Demirkaya, Erkan] Univ Western Ontario, Schulich Sch Med & Dent, Div Paediat Rheumatol, Dept Paediat, London, ON N6A 5W9, Canada; [Romano, Micol; Piskin, David; Demirkaya, Erkan] Univ Western Ontario, Schulich Sch Med Dent, Canadian Behcet & Autoinflammatory Dis Ctr CAN BE, London, ON N6A 5W9, Canada; [Garcia-Bournissen, Facundo] Univ Western Ontario, Schulich Sch Med & Dent, Div Paediat Clin Pharmacol, Dept Paediat, London, ON N6A 5W9, Canada; [Garcia-Bournissen, Facundo; Piskin, David; Demirkaya, Erkan] Univ Western Ontario, Schulich Sch Med & Dent, Dept Epidemiol & Biostat, London, ON N6A 3K7, Canada; [Rodoplu, Ulkumen] Emergency Med Assoc Turkey All, TR-35220 Izmir, Turkey; [Piskin, Lizzy] Univ Western Ontario, Robarts Res Inst, London, ON N6A 3K7, Canada; [Elzagallaai, Abdelbaset A.] Univ Western Ontario, Schulich Sch Med & Dent Physiol & Pharmacol, London, ON N6A 3K7, Canada; [Tuncer, Tunc] Epigenet Hlth Solut, Biochem Unit, TR-06810 Ankara, Turkey; [Sezer, Siren] Atilim Univ, Div Nephrol, Fac Med, TR-06830 Ankara, Turkey; [Ucuncuoglu, Didar] Cankiri Karatekin Univ, Dept Food Engn, Fac Engn, TR-18100 Cankiri, Turkey; [Honca, Tevfik] Gur Life Hosp, Biochem Unit, TR-26320 Eskisehir, Turkey; [Poddighe, Dimitri] Nazarbayev Univ, Dept Med, Sch Med, Nur Sultan 010000, Kazakhstan; [Poddighe, Dimitri] Univ Med Ctr, Natl Res Ctr Maternal & Child Hlth, Clin Acad, Dept Pediat, Nur Sultan 010000, Kazakhstan; [Yavuz, Izzet] Lokman Hekim Univ, Dept Nephrol, TR-06510 Ankara, Turkey; [Stenvinkel, Peter] Karolinska Univ Hosp, Karolinska Inst, Dept Renal Med 99, S-17164 Stockholm, Sweden; [Yilmaz, Mahmut Ilker] Ctr Epigenet Hlth Solut, Nephrol Unit, TR-06810 Ankara, Turkey | en_US |
dc.description | GARCIA-BOURNISSEN, FACUNDO/0000-0002-8732-247X; Poddighe, Dimitri/0000-0001-6431-9334; Ucuncuoglu, Didar/0000-0002-2640-5976; Demirkaya, Erkan/0000-0003-4525-1789; sezer, siren/0000-0002-7326-8388; Stenvinkel, Peter/0000-0002-8785-4820; honca, tevfik/0000-0003-3723-1374 | en_US |
dc.description.abstract | We aimed to evaluate the effect of a combination of natural products on parameters related to inflammation, endothelial dysfunction, and oxidative stress in a cohort of familial Mediterranean fever (FMF) patients with Serum Amyloid A amyloidosis, in a non-randomized, 24-week open-label interventional study. Morinda citrifolia (anti-atherosclerotic-AAL), omega-3 (anti-inflammatory-AIC), and extract with Alaskan blueberry (antioxidant-AOL) were given to patients with FMF-related biopsy-proven AA amyloidosis. Patients were >18 years and had proteinuria (>3500 mg/day) but a normal estimated glomerular filtration rate (eGFR). Arterial flow-mediated dilatation (FMD), carotid intima media thickness (CIMT), and serum biomarkers asymmetric dimethylarginine (ADMA), high sensitivity C-reactive protein (hs-CRP), pentraxin (PTX3), malondialdehyde (MDA), Cu/Zn-superoxide dismutase (Cu/Zn-SOD), and glutathione peroxidase (GSH-Px) were studied at baseline and after 24 weeks of treatment. A total of 67 FMF-related amyloidosis patients (52 male (77.6%); median age 36 years (range 21-66)) were enrolled. At the end of a 24-week treatment period with AAL, AIC, and AOL combination therapy, ADMA, MDA, PTX3, hsCRP, cholesterol, and proteinuria were significantly decreased compared to baseline, while CuZn-SOD, GSH-Px, and FMD levels were significantly increased. Changes in inflammatory markers PTX3, and hsCRP were negatively correlated with FMD change, and positively correlated with decreases in proteinuria, ADMA, MDA, cholesterol, and CIMT. Treatment with AAL, AIC and AOL combination for 24 weeks were significantly associated with reduction in inflammatory markers, improved endothelial functions, and oxidative state. Efficient control of these three mechanisms can have long term cardiovascular and renal benefits for patients with AA amyloidosis. | en_US |
dc.description.sponsorship | Department of Pediatrics, University of Western Ontario, Canada | en_US |
dc.description.sponsorship | The authors thank all the patients who took part in this study. M.R. is the recipient of matching the fund (Department of Pediatrics, University of Western Ontario, Canada) bursary for international clinical fellowship in Behcet and Autoinflammatory Disease Center. | en_US |
dc.identifier.citation | 2 | |
dc.identifier.doi | 10.3390/life12060896 | |
dc.identifier.issn | 2075-1729 | |
dc.identifier.issue | 6 | en_US |
dc.identifier.pmid | 35743929 | |
dc.identifier.scopus | 2-s2.0-85132728702 | |
dc.identifier.uri | https://doi.org/10.3390/life12060896 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14411/1775 | |
dc.identifier.volume | 12 | en_US |
dc.identifier.wos | WOS:000816662000001 | |
dc.language.iso | en | en_US |
dc.publisher | Mdpi | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | familial Mediterranean fever | en_US |
dc.subject | AA amyloidosis | en_US |
dc.subject | natural supplementation | en_US |
dc.subject | endothelial dysfunction | en_US |
dc.subject | oxidative stress | en_US |
dc.subject | inflammation | en_US |
dc.title | Anti-Inflammatory, Antioxidant, and Anti-Atherosclerotic Effects of Natural Supplements on Patients with FMF-Related AA Amyloidosis: A Non-Randomized 24-Week Open-Label Interventional Study | en_US |
dc.type | Article | en_US |
dspace.entity.type | Publication |